Ran Zheng
Directeur/Membre du Conseil chez CARIBOU BIOSCIENCES, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Ran Zheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur/Membre du Conseil | 24/09/2021 | - |
| Independent Dir/Board Member | 24/09/2021 | - | |
| Landmark Bio PBLLC | Directeur/Membre du Conseil | 01/03/2021 | - |
| Directeur Général | 01/03/2021 | - |
Historique de carrière de Ran Zheng
Anciens postes connus de Ran Zheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ORCHARD THERAPEUTICS PLC | Directeur Technique/Scientifique/R&D | 18/03/2019 | 01/02/2021 |
| AMGEN INC. | Corporate Officer/Principal | - | - |
Formation de Ran Zheng
| Beijing Forestry University | Undergraduate Degree |
| University of Minnesota | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 2 |
| Chine | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
| Landmark Bio PBLLC |
